Search Within

Helena Alexandra Yu

Formats
  1. Meeting Abstract (162)
  2. Journal Article (109)
  3. Editorial (9)
  4. Review (7)
  5. Book Section (2)
  6. Correspondence (2)
  7. Conference Paper (1)
Groups
  1. Department of Medicine (292)
  2. Solid Tumor Oncology Division (292)
  3. Thoracic Oncology (292)
  4. GSK Faculty (121)
  5. Department of Pathology and Laboratory Medicine (105)
  6. Human Oncology and Pathogenesis Program (102)

More Groups

People
  1. Gregory Riely (108)
  2. Mark Kris (95)
  3. Marc Ladanyi (71)
  4. Charles Rudin (58)
  5. Maria Arcila (56)
  6. Alexander Drilon (36)

More People

Years
  1. 2025 (21)
  2. 2024 (28)
  3. 2023 (30)
  4. 2022 (33)
  5. 2021 (30)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (75)
  2. Journal of Thoracic Oncology (63)
  3. Annals of Oncology (27)
  4. Clinical Cancer Research (18)
  5. International Journal of Radiation Oncology, Biology, Physics (14)
  6. Cancer Discovery (9)

More Publications

Publishers
  1. Elsevier Inc. (86)
  2. American Society of Clinical Oncology (85)
  3. American Association for Cancer Research (31)
  4. Oxford University Press (31)
  5. Nature Publishing Group (12)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (292)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study of the highly selective EGFR inhibitor, BLU-701, in patients with EGFR-mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Spira, A. I.; Spigel, D. R.; Camidge, D. R.; De Langen, A.; Kim, T. M.; Goto, K.; Elamin, Y. Y.; Shum, E.; Reckamp, K. L.; Rotow, J. K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of BLU-451, a central nervous system (CNS) penetrant, small molecule inhibitor of EGFR, in incurable advanced cancers with EGFR exon 20 insertion (ex20ins) mutations
    Meeting Abstract

    Spira, A. I.; Yu, H. A.; Sun, L.; Nguyen, D.; Pearson, P.; Shim-Lopez, J.; Hausman, D. F.; Le, X.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P
    Meeting Abstract

    Grant, M. J.; Aredo, J. V.; Starrett, J.; Wurtz, A.; Piotrowska, Z.; Piper-Vallillo, A.; Yu, H. A.; Falcon, C.; Patil, T.; Nguyen, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Journal Article

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Steckler, A.; Bucwinska, W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Rb tumor suppressor in small cell lung cancer: Combined genomic and IHC analysis with a description of a distinct Rb-proficient subset
    Editorial

    Febres-Aldana, C. A.; Chang, J. C.; Ptashkin, R.; Wang, Y.; Gedvilaite, E.; Baine, M. K.; Travis, W. D.; Ventura, K.; Bodd, F.; Yu, H. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; Yu, H. A.; Sen, T.; Rudin, C. M.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of BLU-451, a small molecule inhibitor of EGFR, in EGFR exon 20 insertion-mutant incurable advanced cancers
    Meeting Abstract

    Spira, A.; Yu, H.; Sun, L.; Nguyen, D.; Parepally, J.; Albayya, F.; Patel, S.; Zhang, H.; Zalutskaya, A.; Le, X.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save